Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.
Conditions: Cirrhosis, Liver; Ascites Hepatic Interventions: Drug: Ularitide; Drug: Placebo Sponsors: University of Aarhus; Aarhus University Hospital; ADS AIPHIA Development Services AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials